Pages that link to "Q43737083"
Jump to navigation
Jump to search
The following pages link to Skeletal muscle toxicity associated with raltegravir-based combination antiretroviral therapy in HIV-infected adults (Q43737083):
Displaying 11 items.
- Long-term efficacy and safety of raltegravir in the management of HIV infection (Q27686870) (← links)
- Neurological and psychiatric adverse effects of antiretroviral drugs (Q34039419) (← links)
- Antiretroviral therapy: current drugs (Q34085926) (← links)
- Raltegravir as antiretroviral therapy in HIV/AIDS. (Q38168587) (← links)
- Drug safety profile of integrase strand transfer inhibitors. (Q38193524) (← links)
- Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection (Q38570500) (← links)
- Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex With Men. (Q40292568) (← links)
- Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence. (Q42248762) (← links)
- A safety evaluation of raltegravir for the treatment of HIV. (Q47377203) (← links)
- Management of Antiretrovirals in Critically Ill Patients: Great Progress But Potential Pitfalls (Q87859959) (← links)
- Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients (Q92631030) (← links)